Tiny steroid dose could help tame new arthritis flares
NCT ID NCT07252271
Summary
This study is testing if adding a very low daily dose of the steroid prednisolone to standard treatment helps people newly diagnosed with active rheumatoid arthritis. Over 12 weeks, 112 participants will receive either the steroid or a placebo pill, while also starting standard arthritis medications. Researchers will compare how well the disease is controlled and monitor for side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.